Covid19
AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19 | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/SOCHCUMHS5M5BENO6KXI3AGVC4.jpg)
"An early intervention with our antibody can give a significant reduction in progression to severe disease, with continued protection for more than six months," …
